2024-01-04 07:42:11 ET
DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- Rapid Micro Biosystems, Inc. (NASDAQ: RPID) stated, this morning, that Samsung Biologics selected the Growth Direct platform to automate its microbial quality control processes to deliver increased efficiency, more robust data integrity and scalable quality control operations.
Rapid Micro Biosystems is trading at $1.03, up $0.13 (+14.44%), on 960K shares traded.
Its 52-week range is $0.74 to $1.55. It pulled back from its $1.40 premarket high and doesn’t have the best chart, but today’s volume is on pace set a new 52-week high, so as long as the volume is strong anything is possible.
24/7 market NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of …
The post Samsung Biologics News should help Small Cap set a New 52-week Volume High appeared first on 24/7 Market News .
For further details see:
Samsung Biologics News should help Small Cap set a New 52-week Volume High